Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verve Therapeutics, Inc. | Director | Common Stock | 428K | $4.28M | $10.00 | Sep 18, 2023 | Burt A Adelman 2002 Trust |
Verve Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $10.00 | Sep 18, 2023 | Burt A Adelman 2021 GRAT |
Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 136K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERV | Verve Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
VERV | Verve Therapeutics, Inc. | Dec 31, 2023 | 6 | $0 | 5 | Feb 9, 2024 | Director |
VERV | Verve Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
VERV | Verve Therapeutics, Inc. | May 12, 2022 | 1 | $122K | 4 | May 13, 2022 | Director |
VERV | Verve Therapeutics, Inc. | Mar 15, 2022 | 1 | $85.5K | 4 | Mar 17, 2022 | Director |
VERV | Verve Therapeutics, Inc. | Dec 2, 2021 | 1 | $147K | 4 | Dec 6, 2021 | Director |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director, 10%+ Owner |